Anal HPV Infection and Risk for Anal High-grade Squamous Intraepithelial Lesion Among Thai MSM With Acute HIV Infection
NCT03032575 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2024-11-25
Summary
1\. To determine the prevalence and incidence of anal HSIL and associated risk factors among MSM who initiate ART during AHI.
Conditions
- Human Papillomavirus Infection
Interventions
- BEHAVIORAL
-
SEARCH010/RV254
Sponsors & Collaborators
-
SEARCH Research Foundation
collaborator OTHER -
amfAR, The Foundation for AIDS Research
collaborator OTHER -
TREAT Asia
collaborator UNKNOWN -
Thai Red Cross AIDS Research Centre
lead OTHER
Principal Investigators
-
Nittaya Phanuphak, M.D.,Ph.D. · The Thai Red Cross AIDS Research Centre
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-01-31
- Primary Completion
- 2022-12-31
- Completion
- 2023-10-31
Countries
- Thailand
Study Locations
More Related Trials
-
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
NCT00695422 ·Status: COMPLETED
-
Cohort Study of HIV-1 Incidence Among Clients of the Thai Red Cross AIDS Research Center, Bangkok, Thailand
NCT00713531 ·Status: COMPLETED
-
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
NCT00604175 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women
NCT00006444 ·Status: COMPLETED
-
Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women
NCT01461096 ·Status: COMPLETED ·Phase: PHASE3
-
Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
NCT01209325 ·Status: COMPLETED ·Phase: PHASE2
-
Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men
NCT00428285 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Amphetamine-type Stimulants & Its Relationship With HIV Incidence and Antiretroviral Adherence Among MSM and TG
NCT03198962 ·Status: COMPLETED
-
Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV
NCT01946139 ·Status: COMPLETED ·Phase: NA
-
HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)
NCT02087384 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients
NCT03855176 ·Status: COMPLETED ·Phase: PHASE4
-
Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men
NCT00919997 ·Status: COMPLETED
-
Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV
NCT07090174 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Integration of HPV Vaccination and HPV-based Cervical Screening Into ARV Clinics: the H2VICTORY Trial
NCT05173324 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Thai Prophylactic HIV Vaccine Phase I Study
NCT00333424 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection
NCT04925752 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women
NCT00000758 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men
NCT02716675 ·Status: COMPLETED ·Phase: PHASE2
-
Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men
NCT04142398 ·Status: WITHDRAWN
-
Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial
NCT00337181 ·Status: COMPLETED
-
Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients
NCT01017172 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Immunity at the Genital Mucosa of HIV-1 Infected and Healthy Women
NCT01715103 ·Status: TERMINATED ·Phase: NA
-
Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection
NCT04505501 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers
NCT00122564 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Effects of Using Prime-boost HIVIS DNA and MVA-CMDR Vaccine Regimens With or Without Toll-like Receptor 4 Agonist on HIV Reservoirs in Perinatally HIV Infected Children and Youth
NCT04301154 ·Status: COMPLETED ·Phase: PHASE1